“The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017–2022).”
The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.
“Oncology Segment Dominated the Global Epigenetics Market, by Application, in 2016”
On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.
“Pharmaceutical and Biotechnology Companies to Register the Highest Growth Rate During the Forecast Period”
On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.
“APAC to Witness the Highest Growth Rate During the Forecast Period”
The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus of key market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.
The breakup of primary participants has been mentioned below:
• By Company Type – Tier 1: 35%, Tier 2–40% and Tier 3–25%
• By Designation – C Level: 33%, Director Level: 41%, Others: 26%
• By Region – North America: 35%, Europe: 30%, Asia Pacific: 21%, and RoW: 14%
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).
The report aims at estimating the market size and future growth potential of the epigenetics market for different segments such as product, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the epigenetics market
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the epigenetics market
Market Development: Comprehensive information about lucrative emerging markets, by product, application, technology, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the epigenetics market
Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the epigenetics market